This is a competitive renewal for years 32 to 36 of the Interdisciplinary Postdoctoral Training Program in Drug Abuse Research at Mount Sinai. We seek to vigorously train a highly talented diverse group of postdoctoral researchers to integrate basic and translational research in the pharmacology, physiology and neurobiology of drug abuse. The program has a long and distinguished history and our past trainees have compiled a gratifying record of achievements. The program has been reconfigured to provide interdisciplinary training that maintains Sinai's historical strengths and takes advantage of new intellectual, educational, programmatic and physical resources of the school. Under the leadership of Dean Dennis Charney, Mount Sinai over the past decade has recruited a highly renowned broad-based faculty in drug abuse research such as L. A. Devi (Director of this training program), Y. Hurd (Co-Director of this program), E. Nestler and most recently Paul Slesinger. Dr. Nestler is the director of the Friedman Brain Research Institute and the chairman of the Department of Neuroscience. He has embarked on a collaborative program with the Dr. Wayne Goodman, Chairman of the Department of Psychiatry to further develop live imaging modalities in substance abuse research. The postdoctoral training program will train inter- and trans-disciplinary researchers who can go to develop independent and collaborative research programs that significantly advance the basic understanding and treatment of this important social and medical problem. The training program encourages participation of faculty mentors whose research grants specifically target drug abuse, as well as those whose research is critically important for the interdisciplinary training we seek to impart; thus offering fellows flexibility in developing truly interdisciplinary research projects between laboratories. The training will have a didactic component to foster quantitative reasoning skills as well as training to understand and maintain awareness of the ethical issues in research. The trainees will be provided with dynamic guidance to develop independent research projects that can serve as the basis to launch successful independent careers in substance abuse research. Mount Sinai provides a fertile environment and significant resources for this important training program that will contribute robustly to the national pipeline of highly trained interdisciplinary investigators working on drug abuse research problem.

Public Health Relevance

We describe a postdoctoral training program that reflects an interdisciplinary vision that will train researchers who can significant advance the basic understanding and treatment of drug addiction that is an important social and medical problem. This training program also offer fellows flexibility in obtaining basic, translational and clinical training in drug abuse research.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Institutional National Research Service Award (T32)
Project #
5T32DA007135-33
Application #
9087179
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Babecki, Beth
Project Start
1979-12-01
Project End
2019-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
33
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Pharmacology
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Mazzone, C M; Pati, D; Michaelides, M et al. (2018) Acute engagement of Gq-mediated signaling in the bed nucleus of the stria terminalis induces anxiety-like behavior. Mol Psychiatry 23:143-153
Rabin, Rachel A; Dermody, Sarah S; George, Tony P (2018) Changes in tobacco consumption in cannabis dependent patients with schizophrenia versus non-psychiatric controls during 28-days of cannabis abstinence. Drug Alcohol Depend 185:181-188
Lueptow, Lindsay M; Devi, Lakshmi A; Fakira, Amanda K (2018) Targeting the Recently Deorphanized Receptor GPR83 for the Treatment of Immunological, Neuroendocrine and Neuropsychiatric Disorders. Prog Mol Biol Transl Sci 159:1-25
Alia-Klein, Nelly; Preston-Campbell, Rebecca N; Moeller, Scott J et al. (2018) Trait anger modulates neural activity in the fronto-parietal attention network. PLoS One 13:e0194444
Miller, M L; Ren, Y; Szutorisz, H et al. (2018) Ventral striatal regulation of CREM mediates impulsive action and drug addiction vulnerability. Mol Psychiatry 23:1328-1335
Bachi, Keren; Sierra, Salvador; Volkow, Nora D et al. (2017) Is biological aging accelerated in drug addiction? Curr Opin Behav Sci 13:34-39
Lueptow, Lindsay M (2017) Novel Object Recognition Test for the Investigation of Learning and Memory in Mice. J Vis Exp :
Obiorah, Ifeanyi V; Muhammad, Hamza; Stafford, Khalifa et al. (2017) THC Treatment Alters Glutamate Receptor Gene Expression in Human Stem Cell-Derived Neurons. Mol Neuropsychiatry 3:73-84
Michaelides, Michael; Miller, Michael L; DiNieri, Jennifer A et al. (2017) Dopamine D2 Receptor Signaling in the Nucleus Accumbens Comprises a Metabolic-Cognitive Brain Interface Regulating Metabolic Components of Glucose Reinforcement. Neuropsychopharmacology 42:2365-2376
Smith, Alexander C W; Scofield, Michael D; Heinsbroek, Jasper A et al. (2017) Accumbens nNOS Interneurons Regulate Cocaine Relapse. J Neurosci 37:742-756

Showing the most recent 10 out of 115 publications